JP2011518136A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011518136A5 JP2011518136A5 JP2011504180A JP2011504180A JP2011518136A5 JP 2011518136 A5 JP2011518136 A5 JP 2011518136A5 JP 2011504180 A JP2011504180 A JP 2011504180A JP 2011504180 A JP2011504180 A JP 2011504180A JP 2011518136 A5 JP2011518136 A5 JP 2011518136A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- hydroxyestradi
- epoxy
- woman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12362208P | 2008-04-09 | 2008-04-09 | |
| US61/123,622 | 2008-04-09 | ||
| PCT/US2009/040102 WO2009126825A1 (en) | 2008-04-09 | 2009-04-09 | Steroid treatment for hot flashes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011518136A JP2011518136A (ja) | 2011-06-23 |
| JP2011518136A5 true JP2011518136A5 (enExample) | 2012-05-31 |
| JP5524177B2 JP5524177B2 (ja) | 2014-06-18 |
Family
ID=41162250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011504180A Active JP5524177B2 (ja) | 2008-04-09 | 2009-04-09 | ほてりのためのステロイド治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20090258040A1 (enExample) |
| EP (1) | EP2278880B1 (enExample) |
| JP (1) | JP5524177B2 (enExample) |
| KR (1) | KR101602802B1 (enExample) |
| CN (1) | CN102056484B (enExample) |
| AU (1) | AU2009234159B2 (enExample) |
| BR (1) | BRPI0910637A2 (enExample) |
| DK (1) | DK2278880T3 (enExample) |
| MX (1) | MX2010011063A (enExample) |
| WO (1) | WO2009126825A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018297270B2 (en) * | 2017-07-06 | 2024-02-15 | Dignity Health | Novel treatment for hot flushes |
| EP3955933B1 (en) * | 2019-04-15 | 2023-11-29 | Vistagen Therapeutics, Inc. | Treatment of migraine |
| EP4719427A1 (en) * | 2023-06-04 | 2026-04-08 | Vistagen Therapeutics, Inc. | 1,3,5(10),16-estratetraen-3-yl acetate for use in improving psychomotor or cognitive performance |
| WO2025217068A1 (en) * | 2024-04-08 | 2025-10-16 | Vistagen Therapeutics, Inc. | Treatment of dysmenorrhea |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1158966B (de) * | 1961-04-29 | 1963-12-12 | Schering Ag | Verfahren zur Herstellung von 6-Chlor-1, 2ª-methylen-í¸-17ª-hydroxyprogesteronestern |
| US6140316A (en) * | 1991-01-07 | 2000-10-31 | Pherin Corporation | Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
| US5303703A (en) * | 1991-10-03 | 1994-04-19 | Pherin Corporation | Combined neuroepithelial sample delivery electrode device and methods of using same |
| US6117860A (en) * | 1994-08-04 | 2000-09-12 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia |
| US6066627A (en) * | 1994-08-04 | 2000-05-23 | Pherin Corporation | Steroids as neurochemical initiators of change in human blood levels of LH |
| US6057439A (en) | 1994-08-04 | 2000-05-02 | Pherin Corporation | Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety |
| US6331534B1 (en) * | 1994-08-04 | 2001-12-18 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to alleviate pain |
| US5994333A (en) * | 1994-08-04 | 1999-11-30 | Pherin Corporation | Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| US5563131A (en) * | 1994-08-04 | 1996-10-08 | Pherin Corporation | Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| US5792757A (en) * | 1994-08-04 | 1998-08-11 | Pherin Pharmaceuticals | 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
| ATE342721T1 (de) * | 1996-07-23 | 2006-11-15 | Pherin Pharm Inc | Steroide als neurochemische stimulatoren des nasenraumes zur linderung der prämenstrualen symptome |
| US6165504A (en) * | 1998-09-23 | 2000-12-26 | Barr Laboratories, Inc. | Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients |
| US6613758B1 (en) | 1999-04-02 | 2003-09-02 | Barr Laboratories, Inc. | Method for treating osteoporosis in castrated prostatic cancer patients |
| US6756366B1 (en) * | 1999-04-06 | 2004-06-29 | Akzo Nobel N.V. | Orally active androgens |
| US20030045514A1 (en) * | 2001-05-03 | 2003-03-06 | Louis Monti | 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors |
| US7482029B2 (en) * | 2005-04-01 | 2009-01-27 | Bionovo, Inc. | Composition for treatment of menopause |
| ES2433251T5 (es) * | 2005-11-14 | 2020-03-13 | Teva Pharmaceuticals Int Gmbh | Anticuerpos antagonistas dirigidos contra un péptido relacionado con el gen de la calcitonina y procedimientos que utilizan los mismos |
| US20080293683A1 (en) * | 2007-05-24 | 2008-11-27 | University Of Kansas Medical Center | Hormone Replacement Therapy |
-
2009
- 2009-04-09 EP EP09729838A patent/EP2278880B1/en active Active
- 2009-04-09 DK DK09729838.4T patent/DK2278880T3/da active
- 2009-04-09 MX MX2010011063A patent/MX2010011063A/es active IP Right Grant
- 2009-04-09 WO PCT/US2009/040102 patent/WO2009126825A1/en not_active Ceased
- 2009-04-09 JP JP2011504180A patent/JP5524177B2/ja active Active
- 2009-04-09 BR BRPI0910637-5A patent/BRPI0910637A2/pt not_active IP Right Cessation
- 2009-04-09 AU AU2009234159A patent/AU2009234159B2/en active Active
- 2009-04-09 CN CN200980121663.6A patent/CN102056484B/zh active Active
- 2009-04-09 US US12/421,421 patent/US20090258040A1/en not_active Abandoned
- 2009-04-09 KR KR1020107025191A patent/KR101602802B1/ko active Active
-
2011
- 2011-11-03 US US13/288,778 patent/US8431559B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL203747A (en) | Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it | |
| JP2012524112A5 (enExample) | ||
| JP2011225596A5 (enExample) | ||
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| JP2011513437A5 (enExample) | ||
| MX2013003523A (es) | Composicion farmaceutica de dosis baja. | |
| KR20120085353A (ko) | 가금류, 가축의 조류독감 및 호흡기 질환 치료제 및 예방제 | |
| MY172530A (en) | Method for treating gynecological diseases | |
| Santini | Human respiratory syncytial virus and Th1 chemokines | |
| JP2016504361A5 (enExample) | ||
| CN105327069A (zh) | 一种疏肝中草药组合物的配方、制备方法及应用 | |
| JP2019535830A5 (enExample) | ||
| RU2015139515A (ru) | Комбинированное лечение | |
| CN103784590B (zh) | 一种止脱生发中药配方 | |
| CL2015003014A1 (es) | Composición farmacéutica que comprende 0,5-5 mg de (11?,17?)-17-hidroxi-11-[4-(metilsulfonil)fenil]-17-(pentafluoroetil)estra-4,9-dien-3-ona; forma de dosificación oral; uso para tratar y/o prevenir una enfermedad ginecológica, tal como, fibroides en el útero, endometriosis o hemorragias menstruales excesivas. | |
| CN104666531A (zh) | 一种小儿退热贴及其制备方法 | |
| Bhadra et al. | Role of oral misoprostol for treatment of incomplete abortion | |
| CN107714777A (zh) | 一种促进口腔溃疡痊愈的药物 | |
| CN102485242B (zh) | 一种疏风清热解毒利咽的中药组合物及制备方法 | |
| CN102068676A (zh) | 一种治疗冻疮的药物 | |
| CN104224808A (zh) | 米诺环素用于妊娠期间应激所致的后代神经精神损伤的保护作用 | |
| CN106176967B (zh) | 一种舒张气管平滑肌的药物组合物 | |
| CN101579389A (zh) | 一种治疗骨质疏松症的药物组合物 | |
| JP2010519274A5 (enExample) | ||
| CN103893413A (zh) | 一种用于治疗湿疹或皮肤瘙痒的药物组合物及制备方法 |